Clinical Trial: A Study of TAK-279 in Adults With or Without Liver Damage
Study Status: Completed
Recruit Status: RECRUITING
Condition: Hepatic Impairment
Study Type: INTERVENTIONAL
Official Title: An Open-Label, Phase 1 Study to Compare Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of TAK-279 in Subjects With or Without Hepatic Impairment
Brief Summary:
The main aim of this study is to find out how the body processes 1 dose of TAK-279 (pharmacokinetics) in participants with liver problems compared to participants without liver problems.Other aims are to check for side effects from TAK-279 and to learn how well participants tolerate 1 dose of TAK-279.The participants will need to stay at the clinic for 11 days.
Read more